Kestrel Ophthalmics

What Kestrel Ophthalmics does

Kestrel Ophthalmics is a privately held UK company founded in 2001 that designs, develops, and manufactures ophthalmic medical devices and pharmaceuticals. The firm's profile indicates a headcount of 11–50 employees and a footprint spanning London and Creekmoor, suggesting both corporate and operational/manufacturing presence. The short description characterizes the business as covering the full value chain — from design through development to manufacturing — within the ophthalmology vertical, serving the medical device and pharmaceutical needs of eye-care practitioners, clinics, and ultimately patients.

The underlying product portfolio and specific technologies are not disclosed in the available data: no product list, certifications, patents, trademarks, or technology stack details were provided. As a manufacturer of both devices and pharmaceuticals in a regulated healthcare vertical, Kestrel would be expected to operate under relevant medical device and pharmaceutical regulatory regimes (e.g., UK MHRA, EU MDR for devices, and GMP standards for pharmaceutical manufacture), but no compliance artifacts are present in the input. The company's own website returned only a verification/loading page, so primary-source content could not be harvested.

The revenue model is similarly undisclosed — no pricing details, distribution channels, customer segments, or named accounts are available. The data set contains no management team, no funding history, no partnerships, and no M&A activity, leaving significant gaps in any investment thesis. At present, the only verifiable facts are the founding year, headcount band, location, sector focus (ophthalmic devices and pharmaceuticals), and private/operating status. Further diligence on product mix, regulatory clearances, customer roster, and financials is required before any investment conclusion.

Name

Kestrel Ophthalmics

Website

https://kestrelophthalmics.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Kestrel Ophthalmics is a privately held UK firm founded in 2001 that designs, develops, and manufactures ophthalmic medical devices and pharmaceuticals for the eye-care market, operating with a headcount of 11–50 employees.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Ophthalmic Goods Manufacturing (339115)

SIC

Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834)

akta.pro primary industry

Ophthalmology Specialty Pharmaceuticals (HLAIACAK)

akta.pro secondary industries

Cornea & External Disease Surgical Devices (Keratoplasty Tools, Cross-Linking Systems, Amniotic Membrane Delivery) (HLAHAJAK), Ocular Drug Delivery Devices (Eye Droppers/Inserts) (HLAHAIAL)

Keywords

• Ophthalmic medical devices
• Ophthalmic pharmaceuticals
• Eye care products
• Medical device manufacturing
• Ophthalmic drug delivery

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Core offering

Kestrel Ophthalmics designs, develops, and manufactures ophthalmic medical devices and pharmaceuticals. The company operates as a small UK-based manufacturer serving the eye-care sector, with its headquarters in London and an operational footprint referenced at Creekmoor. Specific product lines, formulations, or device categories are not detailed in the available sources.

Differentiator

Problem solved

Functional benefit

Products and services

• Ophthalmic medical devices Design, development, and manufacturing of ophthalmic medical devices for use in eye-care treatment and diagnostics. Specific device SKUs and indications are not detailed in the source data.
• Ophthalmic pharmaceuticals Design, development, and manufacturing of ophthalmic pharmaceutical products supporting eye-care treatment. Specific formulations, dosages, or indications are not detailed in the source data.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• EyePoint Pharmaceuticals: Specialty ophthalmic pharma and drug-delivery company focused on sustained-release treatments for retinal diseases. Directly comparable business model combining ophthalmic pharmaceuticals and delivery-device technology.
• Glaukos Corporation: Ophthalmic medical device company developing novel interventional therapies for glaucoma and corneal health. Comparable as a specialty ophthalmic device developer operating in a similar niche.
• Ocular Therapeutix: US-based specialty ophthalmic company developing sustained-release drug delivery devices and therapeutics. Highly comparable given Kestrel's stated combination of ophthalmic devices and pharmaceuticals.

Emerging players

• Novaliq: Germany-based specialty ophthalmic pharmaceutical company developing water-free topical therapeutics. Comparable as a small, focused European ophthalmic pharma peer.
• Aerie Pharmaceuticals: Specialty ophthalmic pharmaceutical company focused on glaucoma and retinal diseases. Comparable as a small-molecule ophthalmic pharma developer with a similar specialty positioning.
• NuVision Therapeutics: UK-based ophthalmic regenerative medicine and amniotic membrane product developer. Comparable as a small UK ophthalmic specialty firm with overlapping therapeutic categories (cornea/external disease).

Broad incumbents

• Santen Pharmaceutical: Japan-based specialty ophthalmic pharmaceutical and device company with European operations. Comparable as a diversified ophthalmic specialist covering pharma, devices, and combination products.
• Alcon: Global leader in ophthalmic surgical devices, vision care, and pharmaceuticals. Directly comparable as the dominant incumbent covering cataract/IOL devices, contact lenses, and ophthalmic pharma — the same end markets Kestrel Ophthalmics serves.
• Bausch + Lomb: Broad ophthalmic player spanning surgical devices, contact lenses, and pharmaceuticals. Comparable as a diversified incumbent competing across the same device-pharma ophthalmic categories.

Regional players

• Rayner Surgical: UK-based ophthalmic surgical device company specializing in intraocular lenses and cataract surgery products. Highly comparable as a similarly sized UK ophthalmic device manufacturer.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat1 record

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/KestrelO
• LinkedInlinkedin.com/company/kestrel-ophthalmics-ltd-

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kestrel Ophthalmics